Acquisition

With 62 profitable quarters and a major new acquisition, BioSyent prepares to pitch its proven growth strategy to top healthcare investors in Toronto.

Rabbit Hole's new six-year Raceking bourbon blends innovative chocolate-malted grains with Kentucky heritage, making a strategic play in the luxury spirits market.

The struggling footwear brand is selling its assets to become NewBird AI, a GPU provider. Is it a visionary gamble or a desperate move in the AI gold rush?

The multi-asset platform's acquisition of keyless wallet Zengo signals a major shift towards user-controlled finance and heats up the crypto market race.

Investors eye BioCryst's May 6th report for insights into ORLADEYO's growth, a pivotal acquisition, and its strategy in the competitive rare disease market.

After devastating storms, The Ritz-Carlton Oʻahu, Turtle Bay, calls for respectful tourism to help rebuild the North Shore's economy and community.

Despite a historic tariff shock, new data shows middle market dealmaking adapted and thrived, with private equity rewriting its playbook for a new era.

After years of strategic repositioning, Morguard's credit upgrade to investment grade signals enhanced financial power for major new ventures.

Gaia Interactive, backed by Stripe's Bridge, unveils its GUSD stablecoin, aiming to disrupt cross-border payments with a focus on regulation and speed.

Lobbying spending shattered records at $5.3 billion in 2025, driven by battles over trade, taxes, AI, and a surge in Trump-aligned influence firms.

Philip Morris International's upcoming Q1 2026 earnings will be a crucial test of its pivot from cigarettes, with all eyes on ZYN's growth and regulatory hurdles.

As Avnet prepares to report Q3 earnings, investors and tech leaders watch for signs of a sustained recovery in the global electronics supply chain.

The deal accelerates Sanas's infrastructure-first strategy, adding key tech and a serial entrepreneur to rewire how real-time speech AI operates at scale.

Following a major partnership, AST and Marchesini Group will showcase next-gen robotic filling and inspection tech, aiming to reshape sterile drug production.

GCG Advisory Partners partners with Bill Gunderson's $420M firm, leveraging his media empire to build a new fee-only RIA channel in a strategic power play.

Less than a year after a leadership change, Plume’s focus on culture earned it a ‘Most Loved Workplace’ award and ignited a wave of global expansion.

A proposed $108.5M FDA funding boost aims to modernize infant formula rules, paving the way for plant-based options and a more secure supply chain.

Major shareholder and former critic Bill Charters joins the Regis board, bringing financial acumen to steer the salon giant's high-stakes transformation.

The $5.2B timberland manager completes a landmark buyout, becoming one of the largest 100% employee-owned firms in its sector. What does it mean?

French ingredient specialist Vinpai posts higher 2025 sales but a wider net loss, betting its future on the backing of new parent company CAMLIN.